BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine-Reference-Cited by-同舟云学术

BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine

Published:2020-04 Issue: Volume:166 Page:107678
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Chao Po-Kuan,Chang Hsiao-Fu,Chang Wan-Ting,Yeh Teng-Kuang,Ou Li-Chin,Chuang Jian-Ying,Tsu-An Hsu John,Tao Pao-Luh,Loh Horace H.,Shih Chuan,Ueng Shau-Hua,Yeh Shiu-Hwa

Funder

Ministry of Science and Technology

National Health Research Institutes

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference63 articles.

1. Molecular mechanisms of opioid receptor-dependent signaling and behavior;Al-Hasani;Anesthesiology,2011

2. Enhanced morphine analgesia in mice lacking beta-arrestin 2;Bohn;Science,1999

3. Pharmacology of nociceptin and its receptor: a novel therapeutic target;Calo;Br. J. Pharmacol.,2000

4. Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic;Calo;Br. J. Anaesth.,2018

5. Primary afferent tachykinins are required to experience moderate to intense pain;Cao;Nature,1998

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for developing μ opioid receptor agonists with reduced adverse effects;Bioorganic Chemistry;2024-08

2. Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia;Cell Chemical Biology;2024-07

3. Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons;Pharmacology & Therapeutics;2023-11

4. A dual nociceptin and mu opioid receptor agonist exhibited robust antinociceptive effect with decreased side effects;European Journal of Medicinal Chemistry;2023-10

5. Benzo[b]thiophene-2-carboxamides as novel opioid receptor agonists with potent analgesic effect and reduced constipation;European Journal of Medicinal Chemistry;2022-12